Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
Delayed Quote. Delayed Nasdaq - 12/03 04:00:00 pm
344.06 USD   +3.17%
04:52pHealth Care Ticks Lower As Pfizer Gains - Health Care Roundup
DJ
11:31aNotable quotes from the Reuters Next conference
RE
11:13aEuropean ADRs Move Sharply Lower in Friday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer, BioNTech Get US FDA Panel's Endorsement for COVID-19 Vaccine in Children 5 and Up

10/26/2021 | 11:09pm EST


© MT Newswires 2021
All news about BIONTECH SE
04:52pHealth Care Ticks Lower As Pfizer Gains - Health Care Roundup
DJ
11:31aNotable quotes from the Reuters Next conference
RE
11:13aEuropean ADRs Move Sharply Lower in Friday Trading
MT
09:05aBioNTech Capable of Quickly Modifying Vaccine for Omicron Variant, CEO Says
MT
06:42aBioNTech CEO Expects To Modify COVID-19 Vaccine To Omicron Variant
MT
12/02WRAPUP 7-WHO chief scientist urges people not to panic over Omicron
RE
12/02Pfizer-BioNTech, Moderna's COVID-19 Jabs Offer Best Immunity Boost, UK Study Says
MT
12/02Wall Street ends higher in robust rebound from Omicron-driven rout
RE
12/02US Stocks Rebound Following Recent Sell-Offs as Omicron Variant Concerns Subside
MT
12/02Stocks Led Higher Midday by Financials, Energy; GlaxoSmithKline Says Sotrovimab Showed ..
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 17 474 M 19 761 M 19 761 M
Net income 2021 9 220 M 10 426 M 10 426 M
Net cash 2021 9 793 M 11 075 M 11 075 M
P/E ratio 2021 8,03x
Yield 2021 -
Capitalization 71 245 M 80 545 M 80 568 M
EV / Sales 2021 3,52x
EV / Sales 2022 3,01x
Nbr of Employees 2 800
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Last Close Price 294,98 €
Average target price 260,16 €
Spread / Average Target -11,8%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE310.30%80 545
GILEAD SCIENCES, INC.19.58%87 393
REGENERON PHARMACEUTICALS31.23%66 288
WUXI APPTEC CO., LTD.26.31%65 499
VERTEX PHARMACEUTICALS-13.49%51 982
BEIGENE, LTD.36.22%35 545